vimarsana.com
Home
Live Updates
Monoclonal Antibodies Targeting IL-5/IL-5R May Benefit Certa
Monoclonal Antibodies Targeting IL-5/IL-5R May Benefit Certa
Monoclonal Antibodies Targeting IL-5/IL-5R May Benefit Certain Patients With COPD
Chronic obstructive pulmonary disease (COPD) exacerbations and oral corticosteroid use dropped in patients treated with monoclonal antibodies targeting interleukin (IL)-5 and its receptor (IL-5R), a study found.
Related Keywords
,
International Journal Of Chronic Obstructive Pulmonary Disease ,
International Journal ,
Chronic Obstructive Pulmonary Disease ,
Copd ,
Docs ,
Il5 ,
Il5r ,
Exacerbations ,